Clinical Trial Update: Comparing Anti-XA Levels in Post-Cesarean Patients Undergoing Enoxaparin Thromboprophylaxis [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial reports results comparing anti-XA levels in women after cesarean delivery who received enoxaparin thromboprophylaxis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Morbid Obesity
• Obesity
• Pregnancy
• Pulmonary Embolism
• Venous Thromboembolism

Drugs mentioned

• Lovenox (enoxaparin)

Snippet

Sponsor: MemorialCare Health System | Conditions: Obesity, Obesity, Morbid | Phase 1 | Status: COMPLETED | Results posted: 2015-11-23